Chloroquine diphosphate suppresses liver cancer via inducing apoptosis in Wistar rats using interventional therapy

Hao,Xiaoguang; Li,Weijing

doi:10.3892/ol.2021.12494

Chloroquine diphosphate suppresses liver cancer via inducing apoptosis in Wistar rats using interventional therapy

Authors:
- Xiaoguang Hao
- Weijing Li
View Affiliations

Affiliations: Department of Radiology, The Fourth Hospital of Hebei Medicine University, Shijiazhuang, Hebei 050000, P.R. China, Department of Anesthesiology, The Fourth Hospital of Hebei Medicine University, Shijiazhuang, Hebei 050000, P.R. China
Published online on: January 26, 2021 https://doi.org/10.3892/ol.2021.12494
Article Number: 233

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Liver cancer ranks as the second leading cause of cancer‑associated mortality worldwide. To date, neither current ablation therapy nor chemotherapy are considered ideal in improving the outcome of liver cancer. Therefore, more effective therapies for treating this devastating disease are urgently required. Interventional therapy has been used for numerous years in the treatment of different types of cancer, and is characterized by the direct delivery of anticancer drugs into the tumor. It has been reported that antimalarial chloroquine diphosphate (CQ) exerts effective anticancer activity against several types of cancer. However, its effect on liver cancer remains unclear. Therefore, in the present study, 2D monolayer cell culture and 3D spheroid in vitro models, and a rat model, were utilized to investigate the effect of CQ on liver cancer. CQ demonstrated an effective anticancer effect on HepG2 cells and 3D liver spheroids. Furthermore, the drug significantly inhibited cell growth and viability in the 2D and 3D in vitro models. The CQ‑based intervention treatment effectively attenuated tumor size and weight, increased food intake and consumption of drinking water, and improved body weight and survival rate of rats in the in vivo model. In addition, treatment with CQ potently increased the expression levels of the apoptosis‑related genes. Taken together, the findings of the present study may provide a novel insight into the development of safe and effective treatments for liver cancer.

View Figures

View References

1	Yamashita T and Kaneko S: Liver cancer. Rinsho Byori. 64:787–796. 2016.(In Japanese). PubMed/NCBI
2	Li L and Wang H: Heterogeneity of liver cancer and personalized therapy. Cancer Lett. 379:191–197. 2016. View Article : Google Scholar : PubMed/NCBI
3	Anwanwan D, Singh SK, Singh S, Saikam V and Singh R: Challenges in liver cancer and possible treatment approaches. Biochim Biophys Acta Rev Cancer. 1873:1883142020. View Article : Google Scholar : PubMed/NCBI
4	Zheng R, Qu C, Zhang S, Zeng H, Sun K, Gu X, Xia C, Yang Z, Li H, Wei W, et al: Liver cancer incidence and mortality in China: Temporal trends and projections to 2030. Chin J Cancer Res. 30:571–579. 2018. View Article : Google Scholar : PubMed/NCBI
5	Shiraha H, Iwamuro M and Okada H: Hepatic stellate cells in liver tumor. Adv Exp Med Biol. 1234:43–56. 2020. View Article : Google Scholar : PubMed/NCBI
6	Losic B, Craig AJ, Villacorta-Martin C, Martins-Filho SN, Akers N, Chen X, Ahsen ME, von Felden J, Labgaa I, D'Avola D, et al: Intratumoral heterogeneity and clonal evolution in liver cancer. Nat Commun. 11:2912020. View Article : Google Scholar : PubMed/NCBI
7	Guo Z, Chen W, Dai G and Huang Y: Cordycepin suppresses the migration and invasion of human liver cancer cells by downregulating the expression of CXCR4. Int J Mol Med. 45:141–150. 2020.PubMed/NCBI
8	Liu CY, Chen KF and Chen PJ: Treatment of Liver Cancer. Cold Spring Harb Perspect Med. 5:a0215352015. View Article : Google Scholar : PubMed/NCBI
9	Chan LK and Ng IO: Joining the dots for better liver cancer treatment. Nat Rev Gastroenterol Hepatol. 17:74–75. 2020. View Article : Google Scholar : PubMed/NCBI
10	Phillips WT, Bao A, Brenner AJ and Goins BA: Image-guided interventional therapy for cancer with radiotherapeutic nanoparticles. Adv Drug Deliv Rev. 76:39–59. 2014. View Article : Google Scholar : PubMed/NCBI
11	French JT, Goins B, Saenz M, Li S, Garcia-Rojas X, Phillips WT, Otto RA and Bao A: Interventional therapy of head and neck cancer with lipid nanoparticle-carried rhenium 186 radionuclide. J Vasc Interv Radiol. 21:1271–1279. 2010. View Article : Google Scholar : PubMed/NCBI
12	Weyerhäuser P, Kantelhardt SR and Kim EL: Re-purposing chloroquine for glioblastoma: Potential merits and confounding variables. Front Oncol. 8:3352018. View Article : Google Scholar : PubMed/NCBI
13	Borba MGS, Val FFA, Sampaio VS, Alexandre MAA, Melo GC, Brito M, Mourao MPG, Brito-Sousa JD, Baia-da-Silva D, Guerra MVF, et al: Effect of high vs low doses of chloroquine diphosphate as adjunctive therapy for patients hospitalized with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: A randomized clinical trial. JAMA Netw Open. 3:e2088572020. View Article : Google Scholar : PubMed/NCBI
14	Kashyap A, Kaur R, Baldi A, Jain UK, Chandra R and Madan J: Chloroquine diphosphate bearing dextran nanoparticles augmented drug delivery and overwhelmed drug resistance in Plasmodium falciparum parasites. Int J Biol Macromol. 114:161–168. 2018. View Article : Google Scholar : PubMed/NCBI
15	Wei DM, Jiang MT, Lin P, Yang H, Dang YW, Yu Q, Liao DY, Luo DZ and Chen G: Potential ceRNA networks involved in autophagy suppression of pancreatic cancer caused by chloroquine diphosphate: A study based on differentially-expressed circRNAs, lncRNAs, miRNAs and mRNAs. Int J Oncol. 54:600–626. 2019.PubMed/NCBI
16	Jiang PD, Zhao YL, Deng XQ, Mao YQ, Shi W, Tang QQ, Li ZG, Zheng YZ, Yang SY and Wei YQ: Antitumor and antimetastatic activities of chloroquine diphosphate in a murine model of breast cancer. Biomed Pharmacother. 64:609–614. 2010. View Article : Google Scholar : PubMed/NCBI
17	Sasaki K, Tsuno NH, Sunami E, Kawai K, Hongo K, Hiyoshi M, Kaneko M, Murono K, Tada N, Nirei T, et al: Resistance of colon cancer to 5-fluorouracil may be overcome by combination with chloroquine, an in vivo study. Anticancer Drugs. 23:675–682. 2012. View Article : Google Scholar : PubMed/NCBI
18	Godoy P, Hewitt NJ, Albrecht U, Andersen ME, Ansari N, Bhattacharya S, Bode JG, Bolleyn J, Borner C, Bottger J, et al: Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME. Arch Toxicol. 87:1315–1530. 2013. View Article : Google Scholar : PubMed/NCBI
19	Miyamoto Y, Ikeuchi M, Noguchi H, Yagi T and Hayashi S: Spheroid formation and evaluation of hepatic cells in a three-dimensional culture device. Cell Med. 8:47–56. 2015. View Article : Google Scholar : PubMed/NCBI
20	Mazzei M, Vascellari M, Zanardello C, Melchiotti E, Vannini S, Forzan M, Marchetti V, Albanese F and Abramo F: Quantitative real time polymerase chain reaction (qRT-PCR) and RNAscope in situ hybridization (RNA-ISH) as effective tools to diagnose feline herpesvirus-1-associated dermatitis. Vet Dermatol. 30:491–e147. 2019. View Article : Google Scholar : PubMed/NCBI
21	Browning DJ: Pharmacology of chloroquine and hydroxychloroquine. Hydroxychloroquine and Chloroquine Retinopathy. Browning DJ: Springer; New York, NY: pp. 35–63. 2014, View Article : Google Scholar
22	Faustino-Rocha A, Oliveira PA, Pinho-Oliveira J, Teixeira-Guedes C, Soares-Maia R, da Costa RG, Colaco B, Pires MJ, Colaco J, Ferreira R and Ginja M: Estimation of rat mammary tumor volume using caliper and ultrasonography measurements. Lab Anim (NY). 42:217–224. 2013. View Article : Google Scholar : PubMed/NCBI
23	Yin YB, de Jonge HR, Wu X and Yin YL: Mini-gut: A promising model for drug development. Drug Discov Today. 24:1784–1794. 2019. View Article : Google Scholar : PubMed/NCBI
24	Kawai T, Yasuchika K, Ishii T, Miyauchi Y, Kojima H, Yamaoka R, Katayama H, Yoshitoshi EY, Ogiso S, Kita S, et al: SOX9 is a novel cancer stem cell marker surrogated by osteopontin in human hepatocellular carcinoma. Sci Rep. 6:304892016. View Article : Google Scholar : PubMed/NCBI
25	Ferner RE and Aronson JK: Chloroquine and hydroxychloroquine in covid-19. BMJ. 369:m14322020. View Article : Google Scholar : PubMed/NCBI
26	Multicenter collaboration group of Department of Science and Technology of Guangdong Province and Health Commission of Guangdong Province for chloroquine in the treatment of novel coronavirus pneumonia, . Expert consensus on chloroquine phosphate for the treatment of novel coronavirus pneumonia. Zhonghua Jie He He Hu Xi Za Zhi. 43:185–188. 2020.(In Chinese). PubMed/NCBI
27	Aye T and Arndt PA: Utility of chloroquine diphosphate in the blood bank laboratory. Immunohematology. 34:98–102. 2018.PubMed/NCBI
28	Meinao IM, Sato EI, Andrade LE, Ferraz MB and Atra E: Controlled trial with chloroquine diphosphate in systemic lupus erythematosus. Lupus. 5:237–241. 1996. View Article : Google Scholar : PubMed/NCBI
29	Wang J, Wang C, Hu X, Yu C, Zhou L, Ding Z and Zhou M: Gefitinib-mediated apoptosis is enhanced via inhibition of autophagy by chloroquine diphosphate in cutaneous squamous cell carcinoma cells. Oncol Lett. 18:368–374. 2019.PubMed/NCBI
30	Hu T, Li P, Luo Z, Chen X, Zhang J, Wang C, Chen P and Dong Z: Chloroquine inhibits hepatocellular carcinoma cell growth in vitro and in vivo. Oncol Rep. 35:43–49. 2016. View Article : Google Scholar : PubMed/NCBI
31	Fan C, Wang W, Zhao B, Zhang S and Miao J: Chloroquine inhibits cell growth and induces cell death in A549 lung cancer cells. Bioorg Med Chem. 14:3218–3222. 2006. View Article : Google Scholar : PubMed/NCBI
32	Brooks R and Bannigan K: Occupational therapy interventions in child and adolescent mental health: A mixed methods systematic review protocol. JBI Database System Rev Implement Rep. 16:1764–1771. 2018. View Article : Google Scholar : PubMed/NCBI
33	Guan YS and Liu Y: Interventional treatments for hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int. 5:495–500. 2006.PubMed/NCBI
34	Perez-Garijo A, Fuchs Y and Steller H: Apoptotic cells can induce non-autonomous apoptosis through the TNF pathway. Elife. 2:e010042013. View Article : Google Scholar : PubMed/NCBI
35	Wong RS: Apoptosis in cancer: From pathogenesis to treatment. J Exp Clin Cancer Res. 30:872011. View Article : Google Scholar : PubMed/NCBI
36	Pistritto G, Trisciuoglio D, Ceci C, Garufi A and D'Orazi G: Apoptosis as anticancer mechanism: Function and dysfunction of its modulators and targeted therapeutic strategies. Aging (Albany NY). 8:603–619. 2016. View Article : Google Scholar : PubMed/NCBI
37	Liang Q, Xiao Y, Liu K, Zhong C, Zeng M and Xiao F: Cr(VI)-induced autophagy protects L-02 hepatocytes from apoptosis through the ROS-AKT-mTOR pathway. Cell Physiol Biochem. 51:1863–1878. 2018. View Article : Google Scholar : PubMed/NCBI
38	Yan L, Guo N, Cao Y, Zeng S, Wang J, Lv F, Wang Y and Cao X: miRNA-145 inhibits myocardial infarction-induced apoptosis through autophagy via Akt3/mTOR signaling pathway in vitro and in vivo. Int J Mol Med. 42:1537–1547. 2018.PubMed/NCBI
39	Tong Y, Zhang G, Li Y, Xu J, Yuan J, Zhang B, Hu T and Song G: Corilagin inhibits breast cancer growth via reactive oxygen species-dependent apoptosis and autophagy. J Cell Mol Med. 22:3795–3807. 2018.(Epub ahead of print). View Article : Google Scholar
40	Zeng Y, Li S, Wu J, Chen W, Sun H, Peng W, Yu X and Yang X: Autophagy inhibitors promoted aristolochic acid I induced renal tubular epithelial cell apoptosis via mitochondrial pathway but alleviated nonapoptotic cell death in mouse acute aritolochic acid nephropathy model. Apoptosis. 19:1215–1224. 2014. View Article : Google Scholar : PubMed/NCBI
41	Hu H, Gehart H, Artegiani B, LÖpez-Iglesias C, Dekkers F, Basak O, van Es J, Chuva de Sousa Lopes SM, Begthel H, Korving J, et al: Long-term expansion of functional mouse and human hepatocytes as 3D organoids. Cell. 175:1591–1606 e19. 2018. View Article : Google Scholar : PubMed/NCBI
42	Dutta D and Clevers H: Organoid culture systems to study host-pathogen interactions. Curr Opin Immunol. 48:15–22. 2017. View Article : Google Scholar : PubMed/NCBI
43	Yin Y, Chen S, Hakim MS, Wang W, Xu L, Dang W, Qu C, Verhaar AP, Su J, Fuhler GM, et al: 6-Thioguanine inhibits rotavirus replication through suppression of Rac1 GDP/GTP cycling. Antiviral Res. 156:92–101. 2018. View Article : Google Scholar : PubMed/NCBI
44	Angelini F, Corbetti F, Nassuato G, Okolicsanyi L and Zacchi C: Echography with portable equipment. Its possibilities and limits in the hepatobiliary area. Radiol Med. 76:337–339. 1988.(In Italian). PubMed/NCBI
45	Yin YB, de Jonge HR, Wu X and Yin YL: Enteroids for nutritional studies. Mol Nutr Food Res. 63:e18011432019. View Article : Google Scholar : PubMed/NCBI
46	Nuciforo S, Fofana I, Matter MS, Blumer T, Calabrese D, Boldanova T, Piscuoglio S, Wieland S, Ringnalda F, Schwank G, et al: Organoid models of human liver cancers derived from tumor needle biopsies. Cell Rep. 24:1363–1376. 2018. View Article : Google Scholar : PubMed/NCBI
47	Sun L, Wang Y, Cen J, Ma X, Cui L, Qiu Z, Zhang Z, Li H, Yang RZ, Wang C, et al: Modelling liver cancer initiation with organoids derived from directly reprogrammed human hepatocytes. Nat Cell Biol. 21:1015–1026. 2019. View Article : Google Scholar : PubMed/NCBI